ND-646 tagged posts

Novel Cancer Rx has been developed that Halts Fat Synthesis in cells, Stunting Tumors

Salk Institute researchers and collaborators develop novel cancer treatment that halts fat synthesis in cells. Placebo-treated cells (left) have far more lipid (red) production compared to ND-646 treated cells (right). Credit: Image courtesy of Salk Institute

Salk Institute researchers and collaborators develop novel cancer treatment that halts fat synthesis in cells. Placebo-treated cells (left) have far more lipid (red) production compared to ND-646 treated cells (right). Credit: Image courtesy of Salk Institute

Cells create their own fat molecules to build their plasma membranes and other critical structures. Now, researchers at the Salk Institute, along with academic and industry collaborators, have found a way to obstruct this instrumental process to stifle cancer’s growth. The approach stalls the molecular building blocks cancer needs to grow. “Cancer cells rewire their metabolism to support their rapid division,” says Salk Professor Reuben Shaw...

Read More